RecruitingNCT01644903

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Sponsor

Northwestern University

Enrollment

1,000 participants

Start Date

Apr 1, 2010

Study Type

OBSERVATIONAL

Conditions

Chronic Kidney Disease Liver Transplant Hepatitis C Acute Rejection

Summary

This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is monitoring liver transplant recipients by analyzing proteins and genetic material in blood and tissue samples over time to detect early signs of rejection or complications — with the goal of improving long-term outcomes after liver transplantation. **You may be eligible if...** - You are 18 years or older, of any gender or race - You are receiving a liver transplant (from either a living or deceased donor), whether for the first time or not - You or your guardian can provide informed consent and agree to follow the study procedures **You may NOT be eligible if...** - You or your guardian is unable or unwilling to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.